Dozens of compounds approved for other purposes can kill cancer cells selectively
It comes in many types that each require specialized treatment, and scientists are learning to diagnose different varieties
The first research center of its kind in the country is bringing renewed rigor to the investigation of the drugs’ therapeutic uses
Even combination therapies do not prevent such pathogens from becoming resistant
The pathogen has been newly identified in eight cases of encephalitis in Germany over the past 20 years
Our most powerful painkillers can actually make some patients more sensitive to pain
The most widely used antivenom is not effective against the venom of several common snakes
A Chinese Court jailed He Jiankui for an “illegal medical practice” in editing embryos’ DNA
New therapies for beloved pets are getting developed in hopes of treating humans as well
The first to be approved in the United States, the vaccine protects against the virus responsible for the current outbreak in the Democratic Republic of the Congo...
The technology embeds immunization records into a child’s skin
The proposals, which are still under review, are a step toward allowing drugs to be imported from Canada and other countries
A mouse study demonstrates it is possible to separate the substance’s ability to enhance sociability from its addictive potential
As the number of precision medicines grows, so does the challenge of assuring their quality. Solutions are waiting in the wings.
An emerging measure for predicting cancer treatment outcomes could dramatically speed clinical trials and the approval of new therapies. What stands in the way?
Will the benefits of aducanumab be enough to justify FDA approval, given its small benefit and high price?
The “Ready, Set, PrEP” program will provide donated drugs that could protect up to 200,000 people a year for 11 years
Although not practical in many areas, the approach reveals clues to how the immune system battles the infection
Former Enron employee John Arnold and his wife Laura have financed much of the Democrats’ efforts to cut prescription drug costs
Students were given placebos and told they were placebos, yet the intervention helped